Cimpress plc held its Annual General Meeting of Shareholders on December 17, 2025. Shareholders approved the reappointment of Robert S. Keane and Scott J. Vassalluzzo to the Board of Directors. Authority was renewed for the Board of Directors to issue authorized but unissued ordinary shares up to a maximum of 20% of the issued and outstanding share capital until June 17, 2027. Shareholders also renewed the authority of the Board of Directors to opt out of statutory preemption rights under Irish law with respect to the issuance of ordinary shares for cash, up to a maximum of 20% of the issued and outstanding share capital, until June 17, 2027. PricewaterhouseCoopers Ireland was reappointed as statutory auditor to hold office until the conclusion of the next annual general meeting, and the Board of Directors or Audit Committee was authorized to determine the remuneration of PricewaterhouseCoopers Ireland in its capacity as statutory auditor. All proposals were approved.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cimpress plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001262976-25-000122), on December 22, 2025, and is solely responsible for the information contained therein.